Bio-Techne Corporation
TECH
$48.21
$0.841.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 109.56M | 81.10M | 77.99M | 73.40M | 131.67M |
| Total Depreciation and Amortization | 56.33M | 59.73M | 62.11M | 65.90M | 64.25M |
| Total Amortization of Deferred Charges | 44.00M | 44.00M | 44.00M | 44.00M | 46.60M |
| Total Other Non-Cash Items | 108.51M | 96.40M | 88.73M | 92.71M | 42.60M |
| Change in Net Operating Assets | -23.55M | -31.92M | -21.57M | 11.54M | -20.27M |
| Cash from Operations | 294.86M | 249.32M | 251.25M | 287.56M | 264.85M |
| Capital Expenditure | -25.26M | -26.30M | -27.20M | -31.01M | -44.10M |
| Sale of Property, Plant, and Equipment | 5.28M | 5.28M | 7.06M | 2.45M | 1.79M |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.26M | 7.24M | 7.24M | -6.62M | -2.09M |
| Cash from Investing | -10.73M | -13.78M | -12.89M | -35.18M | -44.40M |
| Total Debt Issued | 66.00M | 104.00M | 104.00M | 104.00M | 38.00M |
| Total Debt Repaid | -196.00M | -144.00M | -104.00M | -77.00M | -97.00M |
| Issuance of Common Stock | 64.42M | 49.33M | 50.13M | 51.74M | 68.45M |
| Repurchase of Common Stock | -110.96M | -211.14M | -286.52M | -282.25M | -182.36M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -49.82M | -49.88M | -50.15M | -50.39M | -50.63M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -226.36M | -251.69M | -286.54M | -253.91M | -223.55M |
| Foreign Exchange rate Adjustments | 11.38M | 11.48M | 5.60M | 11.93M | 3.85M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.15M | -4.67M | -42.58M | 10.40M | 755.00K |